TARPLIN, DOWNS & YOUNG, LLC

Lobbying for NOVARTIS · Use innovative science and technology to discover & develop breakthrough treatments

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $60,000.00 income · posted Jul 20, 2026

Lobbying activity 4

Medicare/Medicaid

Lobbying related to pharmaceutical policy

Trade (domestic/foreign)

Lobbying related to trade

Budget/Appropriations

Federal budget issues

Health Issues

Lobbying related to pharmaceutical policy

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.